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Dear Editor,
We read with interest the article of Kellen et al.1 We are
encouraged by the positive response to self-sampling, particu-
larly among postmenopausal women. However, we were
struck by the findings that DNA concentration decreased as a
function of age. In an ongoing longitudinal study of oral and
cervical HPV prevalence at the University of Michigan, using
the HerSwab self-collection kit and covering women from ages
18 to 70, we find no such age relationship with DNA concen-
tration.2 This result appears consistent regardless of whether
we control for time between collection and preservation in
PreservCyt media, the time from preservation to extraction,
and HPV result (Invalid vs. Positive/Negative).
Participants collected 1–6 samples over 2 years for a total
of 317 samples. The left panel of Figure 1 shows the distribu-
tion of DNA concentrations from the baseline (first visit) vag-
inal self-samples collected by our study participants by age,
for age groups 18–29 (n = 91 individuals), 30–39 (n = 12 indi-
viduals), 40–49 (n = 7 individuals), 50–59 (n = 11 individ-
uals), and 60+ (n = 7 individuals). About half of the study
samples are from college-age individuals, thus the larger num-
ber and variability for the youngest age group. The right panel
Figure 1. Left panel: DNA concentration (ng/μL) distributions of self-sample taken at the first study visit by age groups; 18–29 (n = 91
individuals), 30–39 (n = 12 individuals), 40–49 (n = 7 individuals), 50–59 (n = 11 individuals), and ≥60 (n = 7 individuals). Right panel:
DNA concentration of self-samples taken by study participants over ≥1 visit by age-group; 18–29 (n = 10 individuals, 25 samples), 30–39
(n = 12 individuals, 37 samples), 40–49 (n = 7 individuals, 17 samples), 50–59 (11 individuals, 37 samples), and 60+ (7 individuals,
19 samples). Each boxplot corresponds to a study participant. The right panel shows all study participants of ages ≥30, but only a random
subsample of 10 participants of ages 18–29 (due to space constraints).
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shows individual mean and ranges of self-sample DNA con-
centration, that is, samples from single individuals collected
over two years by age group; 18–29 (n = 10 individuals,
25 samples), 30–39 (n = 12 individuals, 37 samples), 40–49
(n = 7 individuals, 17 samples), 50–59 (11 individuals, 37 sam-
ples), and 60+ (7 individuals, 19 samples). The panel shows
all study individuals of ages ≥30, but only a random subsam-
ple of 10 individuals of ages 18–29 (due to space constraints).
As shown in the figure, there can be considerable variability
in the DNA concentration from self-collected samples from
the same individual, collected a few months apart, but there is
little to suggest there are trends by age.
The lack of association between age and DNA
concentration—that is, no decrease with age—is consistent
with the results briefly reported by Kellen et al. in the discus-
sion section when using the Evalyn brush instead of the Qvin-
tip brush. Thus, we strongly agree with Kellen et al. that
additional studies are needed to assess the relative accuracy
and performance of different self-sampling devices in combi-
nation with specific HPV-tests and in specific sociodemo-
graphic groups.3 Such studies should ideally control for
additional factors such as the time between collection and
DNA extraction and HPV test result, and storage conditions.4
We commend Kellen et al. for their article and suggest that
other self-sampling studies assess and report the levels of
DNA concentration, at least for a sub-sample. Given the high
uptake of self-sampling for HPV testing among post-
menopausal women, it is critical to identify the optimal
screening protocol and devices for them.
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